Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Urban Health ; 100(2): 245-254, 2023 04.
Article in English | MEDLINE | ID: mdl-37016269

ABSTRACT

In November of 2021, multiple factors converged to create a window of opportunity to open overdose prevention centers (OPCs) at two existing syringe service programs (SSPs) in New York City (NYC). Political will exists in NYC, particularly toward the end of the de Blasio administration's term, and the NYC Health Department worked to garner additional support from local and state elected officials given the dire need to address the overdose crisis. This coincided with readiness on the part of one of the NYC SSP providers, OnPoint NYC, to open and operate OPC services. Legal risks were assessed by both the city and the provider. This case study outlines the sequence of events that resulted in NYC supporting OnPoint to open the first two publicly recognized OPCs in the nation, including lessons learned to inform other jurisdictions considering offering such services.


Subject(s)
Drug Overdose , Humans , New York City , Drug Overdose/epidemiology , Drug Overdose/prevention & control
2.
J Law Med Ethics ; 50(3): 613-618, 2022.
Article in English | MEDLINE | ID: mdl-36398639

ABSTRACT

Vaccine mandates played a critical role in the success of New York City's COVID-19 response. By relying on evidence as a substantive basis for the mandates and adhering to procedural requirements and precedent, New York City leveraged its position and expertise as a local governmental authority to devise mandatory vaccine policies that withstood numerous legal challenges. New York City's experience highlights the role of municipal government in mounting a meaningful public health response, and the strategies adopted by NYC may provide a blueprint for municipalities around the world facing the ongoing COVID-19 pandemic and the threat of future public health emergencies.


Subject(s)
COVID-19 , Influenza, Human , Humans , New York City/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Pandemics/prevention & control , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...